BioXcel Therapeutics (BTAI) Change in Receivables (2023 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Change in Receivables of -$17000.0 for Q1 2026, up 87.02% year-over-year from -$9089.8 in Q1 2025, and down 107.3% quarter-over-quarter from $233000.0 in Q4 2025.
BioXcel Therapeutics (BTAI) Change in Receivables (2023 - 2026) Analysis & Trends
BioXcel Therapeutics' Change in Receivables history runs 4 years deep, the most recent figure standing at -$17000.0 for Q1 2026.
- In Q1 2026, Change in Receivables rose 87.02% year-over-year to -$17000.0; the TTM figure through Mar 2026 stood at $216000.0 (up 157.14% YoY), while the FY2025 annual figure was $102000.0, up 70.0% from the prior year.
- Change in Receivables for Q1 2026 stood at -$17000.0, down from $233000.0 in the prior quarter.
- The five-year high for Change in Receivables was $434000.0 in Q2 2024, with the low at -$809000.0 in Q3 2024.
- The 4-year median for Change in Receivables is $35000.0 (2023), against an average of -$2461.5.
- Peak annual rise in Change in Receivables reached 777.14% in 2024, while the deepest fall reached 366.12% in 2024.
- BioXcel Therapeutics' Change in Receivables stood at -$664000.0 in 2023, then jumped by 119.28% to $128000.0 in 2024, then jumped by 82.03% to $233000.0 in 2025, then plunged by 107.3% to -$17000.0 in 2026.
- Business Quant data shows BTAI's Change in Receivables at -$17000.0 in Q1 2026, $233000.0 in Q4 2025, and -$17000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.46 Mn | 24.46 Mn | 160,000.00 | -134,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -134,000.00 |
| Jun 30, 2026 | -134,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Sep 30, 2025 | -17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | -131,000.00 |
| Mar 31, 2025 | -131,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Dec 31, 2024 | 128,000.00 |
| Sep 30, 2024 | -809,000.00 |
| Sep 30, 2024 | -809,000.00 |
| Jun 30, 2024 | 434,000.00 |
| Jun 30, 2024 | 434,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Mar 31, 2024 | 307,000.00 |